156 related articles for article (PubMed ID: 29633591)
1. Targetome Analysis Revealed Involvement of MiR-126 in Neurotrophin Signaling Pathway: A Possible Role in Prevention of Glioma Development.
Rouigari M; Dehbashi M; Ghaedi K; Pourhossein M
Cell J; 2018 Jul; 20(2):150-156. PubMed ID: 29633591
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-675 promotes glioma cell proliferation and motility by negatively regulating retinoblastoma 1.
Zheng Y; Lu X; Xu L; Chen Z; Li Q; Yuan J
Hum Pathol; 2017 Nov; 69():63-71. PubMed ID: 28970140
[TBL] [Abstract][Full Text] [Related]
3. miR-128-3p inhibits glioma cell proliferation and differentiation by targeting NPTX1 through IRS-1/PI3K/AKT signaling pathway.
Huo L; Wang B; Zheng M; Zhang Y; Xu J; Yang G; Guan Q
Exp Ther Med; 2019 Apr; 17(4):2921-2930. PubMed ID: 30906475
[TBL] [Abstract][Full Text] [Related]
4. Anticancer Activity of Erianin: Cancer-Specific Target Prediction Based on Network Pharmacology.
Yan L; Zhang Z; Liu Y; Ren S; Zhu Z; Wei L; Feng J; Duan T; Sun X; Xie T; Sui X
Front Mol Biosci; 2022; 9():862932. PubMed ID: 35372513
[TBL] [Abstract][Full Text] [Related]
5. miR-326 and miR-26a, two potential markers for diagnosis of relapse and remission phases in patient with relapsing-remitting multiple sclerosis.
Honardoost MA; Kiani-Esfahani A; Ghaedi K; Etemadifar M; Salehi M
Gene; 2014 Jul; 544(2):128-33. PubMed ID: 24792898
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA expression data analysis to identify key miRNAs associated with Alzheimer's disease.
Chen J; Qi Y; Liu CF; Lu JM; Shi J; Shi Y
J Gene Med; 2018 Jun; 20(6):e3014. PubMed ID: 29543360
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-126 acts as a tumor suppressor in glioma cells by targeting insulin receptor substrate 1 (IRS-1).
Luan Y; Zuo L; Zhang S; Wang G; Peng T
Int J Clin Exp Pathol; 2015; 8(9):10345-54. PubMed ID: 26617742
[TBL] [Abstract][Full Text] [Related]
8. Hsa-microRNA-181a is a regulator of a number of cancer genes and a biomarker for endometrial carcinoma in patients: a bioinformatic and clinical study and the therapeutic implication.
He S; Zeng S; Zhou ZW; He ZX; Zhou SF
Drug Des Devel Ther; 2015; 9():1103-75. PubMed ID: 25733820
[TBL] [Abstract][Full Text] [Related]
9. A predicted miR-27a-mediated network identifies a signature of glioma.
Yang S; Wang K; Qian C; Song Z; Pu P; Zhang A; Wang W; Niu H; Li X; Qi X; Zhu Y; Wang Y
Oncol Rep; 2012 Oct; 28(4):1249-56. PubMed ID: 22895821
[TBL] [Abstract][Full Text] [Related]
10. Identification of invasion-metastasis-associated microRNAs in hepatocellular carcinoma based on bioinformatic analysis and experimental validation.
Lou W; Chen J; Ding B; Chen D; Zheng H; Jiang D; Xu L; Bao C; Cao G; Fan W
J Transl Med; 2018 Sep; 16(1):266. PubMed ID: 30268144
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-30a suppresses self-renewal and tumorigenicity of glioma stem cells by blocking the NT5E-dependent Akt signaling pathway.
Peng L; Ming Y; Zhang L; Zhou J; Xiang W; Zeng S; He H; Chen L
FASEB J; 2020 Apr; 34(4):5128-5143. PubMed ID: 32067282
[TBL] [Abstract][Full Text] [Related]
12. microRNA-126 inhibits tube formation of HUVECs by interacting with EGFL7 and down-regulating PI3K/AKT signaling pathway.
Li Q; Cheng K; Wang AY; Xu QG; Fu ZF; He SY; Xu PX
Biomed Pharmacother; 2019 Aug; 116():109007. PubMed ID: 31170663
[TBL] [Abstract][Full Text] [Related]
13. Circular RNA hsa_circ_0005114-miR-142-3p/miR-590-5p-adenomatous polyposis coli protein axis as a potential target for treatment of glioma.
Wei B; Wang L; Zhao J
Oncol Lett; 2021 Jan; 21(1):58. PubMed ID: 33281969
[TBL] [Abstract][Full Text] [Related]
14. MiRNA-451 Inhibits Glioma Cell Proliferation and Invasion Through the mTOR/HIF-1α/VEGF Signaling Pathway by Targeting CAB39.
Nan Y; Guo H; Guo L; Wang L; Ren B; Yu K; Huang Q; Zhong Y
Hum Gene Ther Clin Dev; 2018 Sep; 29(3):156-166. PubMed ID: 30180756
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-7 directly targets insulin-like growth factor 1 receptor to inhibit cellular growth and glucose metabolism in gliomas.
Wang B; Sun F; Dong N; Sun Z; Diao Y; Zheng C; Sun J; Yang Y; Jiang D
Diagn Pathol; 2014 Nov; 9():211. PubMed ID: 25394492
[TBL] [Abstract][Full Text] [Related]
16. Erianin, the main active ingredient of Dendrobium chrysotoxum Lindl, inhibits precancerous lesions of gastric cancer (PLGC) through suppression of the HRAS-PI3K-AKT signaling pathway as revealed by network pharmacology and in vitro experimental verification.
Wang Y; Chu F; Lin J; Li Y; Johnson N; Zhang J; Gai C; Su Z; Cheng H; Wang L; Ding X
J Ethnopharmacol; 2021 Oct; 279():114399. PubMed ID: 34246740
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-936 induces cell cycle arrest and inhibits glioma cell proliferation by targeting CKS1.
Wang D; Zhi T; Xu X; Bao Z; Fan L; Li Z; Ji J; Liu N
Am J Cancer Res; 2017; 7(11):2131-2143. PubMed ID: 29218238
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-134 modulates glioma cell U251 proliferation and invasion by targeting KRAS and suppressing the ERK pathway.
Zhao Y; Pang D; Wang C; Zhong S; Wang S
Tumour Biol; 2016 Aug; 37(8):11485-93. PubMed ID: 27012554
[TBL] [Abstract][Full Text] [Related]
19. MiR-383 inhibits proliferation, migration and angiogenesis of glioma-exposed endothelial cells in vitro via VEGF-mediated FAK and Src signaling pathways.
Zhao LN; Wang P; Liu YH; Cai H; Ma J; Liu LB; Xi Z; Li ZQ; Liu XB; Xue YX
Cell Signal; 2017 Jan; 30():142-153. PubMed ID: 27693218
[TBL] [Abstract][Full Text] [Related]
20. Down-regulation of miR-126 is associated with colorectal cancer cells proliferation, migration and invasion by targeting IRS-1 via the AKT and ERK1/2 signaling pathways.
Zhou Y; Feng X; Liu YL; Ye SC; Wang H; Tan WK; Tian T; Qiu YM; Luo HS
PLoS One; 2013; 8(11):e81203. PubMed ID: 24312276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
